Literature DB >> 15645440

Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation.

Michael L Gatza1, Chandtip Chandhasin, Razvan I Ducu, Susan J Marriott.   

Abstract

It is estimated that 15% of all cancers are etiologically linked to viral infection. Specific cancers including adult T-cell leukemia, hepatocellular carcinoma, and uterine cervical cancer are associated with infection by human T-cell leukemia virus type I, hepatitis B virus, and high-risk human papilloma virus, respectively. In these cancers, genomic instability, a hallmark of multistep cancers, has been explicitly linked to the expression of oncoproteins encoded by these viruses. This review discusses mechanisms utilized by these viral oncoproteins, Tax, HBx, and E6/E7, to mediate genomic instability and cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645440     DOI: 10.1002/em.20088

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  12 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

Review 2.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

Review 3.  How virus persistence can initiate the tumorigenesis process.

Authors:  Simone Avanzi; Gualtiero Alvisi; Alessandro Ripalti
Journal:  World J Virol       Date:  2013-05-12

Review 4.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

5.  Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism.

Authors:  Michael L Gatza; Susan J Marriott
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.

Authors:  Il-Seok Park; Xiaofei Chang; Myriam Loyo; Gaosong Wu; Alice Chuang; Myoung Sook Kim; Young Kwang Chae; Sofia Lyford-Pike; William H Westra; John R Saunders; David Sidransky; Sara Isabel Pai
Journal:  Cancer Prev Res (Phila)       Date:  2011-02

7.  Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy.

Authors:  Paolo Conca; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

8.  The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.

Authors:  Agustin F Fernandez; Cecilia Rosales; Pilar Lopez-Nieva; Osvaldo Graña; Esteban Ballestar; Santiago Ropero; Jesus Espada; Sonia A Melo; Amaia Lujambio; Mario F Fraga; Irene Pino; Biola Javierre; Francisco J Carmona; Francesco Acquadro; Renske D M Steenbergen; Peter J F Snijders; Chris J Meijer; Pascal Pineau; Anne Dejean; Belen Lloveras; Gabriel Capella; Josep Quer; Maria Buti; Juan-Ignacio Esteban; Helena Allende; Francisco Rodriguez-Frias; Xavier Castellsague; Janos Minarovits; Jordi Ponce; Daniela Capello; Gianluca Gaidano; Juan Cruz Cigudosa; Gonzalo Gomez-Lopez; David G Pisano; Alfonso Valencia; Miguel Angel Piris; Francesc X Bosch; Ellen Cahir-McFarland; Elliott Kieff; Manel Esteller
Journal:  Genome Res       Date:  2009-02-10       Impact factor: 9.043

9.  Epigenetic mechanisms in virus-induced tumorigenesis.

Authors:  Elzbieta Poreba; Justyna Karolina Broniarczyk; Anna Gozdzicka-Jozefiak
Journal:  Clin Epigenetics       Date:  2011-03-23       Impact factor: 6.551

10.  DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences.

Authors:  Yoshiyuki Watanabe; Hiroyuki Yamamoto; Ritsuko Oikawa; Minoru Toyota; Masakazu Yamamoto; Norihiro Kokudo; Shinji Tanaka; Shigeki Arii; Hiroshi Yotsuyanagi; Kazuhiko Koike; Fumio Itoh
Journal:  Genome Res       Date:  2015-02-04       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.